iCo Therapeutics (ICO) Trading Down 7.1%

iCo Therapeutics Inc (CVE:ICO) shares fell 7.1% during mid-day trading on Monday . The stock traded as low as C$0.07 and last traded at C$0.07. 290,860 shares were traded during trading, a decline of 37% from the average session volume of 461,306 shares. The stock had previously closed at C$0.07.

The stock has a market capitalization of $7.66 million and a PE ratio of -3.25.

TRADEMARK VIOLATION NOTICE: “iCo Therapeutics (ICO) Trading Down 7.1%” was first published by Mayfield Recorder and is the property of of Mayfield Recorder. If you are accessing this article on another domain, it was stolen and republished in violation of U.S. & international copyright law. The original version of this article can be viewed at https://mayfieldrecorder.com/2019/05/29/ico-therapeutics-ico-trading-down-7-1.html.

iCo Therapeutics Company Profile (CVE:ICO)

iCo Therapeutics Inc, a biotechnology company, focuses on the identification, development, and commercialization of drug candidates to treat sight and life threatening diseases. Its in-licensed product candidates include iCo-008, a human monoclonal antibody, which is in Phase II clinical trial to treat sight threatening ocular allergies and various systemic disease indications; and Oral AmpB Delivery System that is in pre-clinical stage used for the treatment of systemic fungal infections.

Further Reading: What is a Roth IRA?

Receive News & Ratings for iCo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iCo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.